Gonadal dysfunction in males with prolactinoma: From functional modification to irreversible damage?

European Journal of Endocrinology

Volumn 136, Issue 6, 1997, Pages 630-

  Delgrange, Etienne ^a   Donckier, Julian ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ARTICLE; GONAD DYSFUNCTION; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SEMEN ANALYSIS; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE;

EID: 0030750108     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360630     Document Type: Letter

References (5)

1. Colao A, De Rosa M, Sarnacchiaro E Di Sarno A, Landi ML, lervolino E et al. Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males. European Journal of Endocrinology 1996 135 548-552.
2. Hulling AL, Muhr C, Lundberg PO & Werner S. Prolactinomas in men: clinical characteristics and the effect of bromocriptine treatment. Acta Medic Scandinavica 1985 217 101-109.
3. Berezin M, Shimon I & Hadani M. Prolactinoma in 53 men: clinical characteristics and modes of treatment. Journal of Endocrinological Investigation 1995 18 436-441.
4. Delgrange E, Tourniaire J, Maiter D, Donckier J, Perrin G & Trouillas J. Le prolactinome chez l'homme. Revue Française Endocrinologie Clinique 1996 37307-317.
5. Murray FT, Cameron DF & Ketchum C. Return of gonadal function in men with prolactin-secreting pituitary tumors. Journal of Clinical Endocrinology and Metabolism 1984 59 79-85.